Macrovascular Complications Flashcards

1
Q

What does macrovascular disease include?

A

o Early widespread atherosclerosis i.e. renal artery stenosis

o IHD (ischaemic)

o Cerebrovascular disease

o Peripheral vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are insulin resisitance and atheromas linked?

A

IR contributed to the first 4 stages of atheroma formation

  1. Inital lesion
  2. Fatty streak
  3. Intermediate
  4. Atheroma
  5. Fibroatheroma
  6. Complicated lesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

First Key Concept?

A

Hyperglycaemia is associated w. significant reduced life expectancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the First Key Concept

A

o If present with diabetes earlier in life - have a SHORTER life expectancy

o Women lose their protection of their gender when they have diabetes in atheroma formation

  • suffer more than men
  • hence why relative risk in women is HIGHER

o metabolic syndrome had been associated with hyperglycaemia

o risk of MICROvascular disease is very much related to sugar
- so if do NOT have diabetes, virtually NO risk

o risk associated w. HbA1C and MACROvascular more linear

  • the higher HbA1C, the greater the risk
  • even people WITHOUT diabetes have a high risk!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Second Key Concept?

A

Microvascular disease causes morbidity

Macrovasular disease causes morbidity AND mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the Second Key Concept

A

o IHD is a big cause of mortality in diabetics

  • diabetics that have NOT had a HA have same mortality has people without diabetes that HAVE had a HA
  • diabetics that appear well likely have IHD

o Malignancy tends to be reduced as a cause of death
- this is many diabetics die before cancer has had chance to manifest

o South Asians have a worse mortality for CHD than white caucasians

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can the Second Key Concept be measured?

A

Farmingham Risk Score

Gender-specific algorithm to estimate 10-year CV event risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Third Key Concept?

A

Macrovascular disease is a systemic disease and is commonly present in multiple arterial beds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the Third Key Concept

A
  1. IHD
    o major cause of morbidity & mortality in diabetics (2nd KC)
    o mechanism similar with or without diabetes
  2. Cerebrovascular disease
    o earlier than without diabetes
    o more widespread
    o uncommon in people <60 years
  3. Peripheral Vascular disease
    o contributed to diabetic foot problems w. neuropathy
  4. Renal artery stenosis
    o may contribute to hypertension in some
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fourth Key Concept?

A

Treatment targeted to hyperglycaemia alone has minor effect on increased risk of CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the Fourth Key Concept

A

Intensive glucose control does improve CHD risk
BUT
it does NOT change mortality much

Management of glucose alone does NOT address vascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fifth Key Concept?

A

Prevention of macrovascular disease required aggressive management of multiple risk factors

(IR before hyperglycaemia itself contributes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risk Factors for macrovascular diease?

A
Non-modifiable
 o age
 o sex
 o birth weight
 o FH/genes
Modifiable
 o dyslipidaemia
 o High BP
 o Smoking
 o Diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the Fifth Key Concept

A

BP & cholesterol also need to managed in T2DM to prevent complications

Takin statins has a significant effect in reducing macrovascular disease risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the treatment goals?

A
  1. Blood-glucose lowering therapy
    via. metaformin, sulphonylurea, insulin etc.
  2. BP measurement
    - if damage to kidneys, eyes or cerebrovascular damage lower considerably (<130/80mmHg)
    - other targets lower less (<140/80mmHg)
    - constant monitoring
  3. Management of blood lipids
    - review CV risk annually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly